Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abatacept: A Review of its Use in the Management of Rheumatoid Arthritis
Authors
Keywords
Juvenile Idiopathic Arthritis, Abatacept, Health Assessment Questionnaire Disability Index, ACR20 Response Rate, Methotrexate Recipient
Journal
DRUGS
Volume 73, Issue 10, Pages 1095-1119
Publisher
Springer Nature
Online
2013-06-21
DOI
10.1007/s40265-013-0080-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- THU0125 A multi-center, double-dummy, double-blind study of subcutaneous (SC) abatacept (ABA) compared with intraveneous (IV) ABA in japanese rheumatoid arthritis patients with inadequate response to methotrexate
- (2014) T. Matsubara et al. ANNALS OF THE RHEUMATIC DISEASES
- AB0567 Safety of SC abatacept in patients with ra: Update from pooled clinical trial data:
- (2014) R. Alten et al. ANNALS OF THE RHEUMATIC DISEASES
- OP0044 Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Two Year Results from the Ample Study
- (2014) M. Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
- (2014) K Malottki et al. HEALTH TECHNOLOGY ASSESSMENT
- Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the phase IIIb ATTUNE study
- (2012) Edward Clark Keystone et al. ANNALS OF THE RHEUMATIC DISEASES
- Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
- (2012) J E Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
- (2012) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
- (2012) M. Bonelli et al. ARTHRITIS AND RHEUMATISM
- Biologic Rheumatoid Arthritis Therapies
- (2012) Marc C. Levesque BIODRUGS
- Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid Arthritis and an Inadequate Response to Tumor Necrosis Factor Inhibitor Therapy
- (2012) MARK C. GENOVESE et al. JOURNAL OF RHEUMATOLOGY
- Phase II dose–response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
- (2012) Tsutomu Takeuchi et al. Modern Rheumatology
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Immunogenicity, Safety, and Efficacy of Abatacept Administered Subcutaneously With or Without Background Methotrexate in Patients With Rheumatoid Arthritis: Results From a Phase III, International, Multicenter, Parallel-Arm, Open-Label Study
- (2012) Peter Nash et al. ARTHRITIS CARE & RESEARCH
- Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
- (2012) Teresa A Simon et al. ARTHRITIS RESEARCH & THERAPY
- Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study)
- (2011) Jeffrey Kaine et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
- (2011) M. Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes
- (2011) J. Bathon et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial
- (2011) J. M. Kremer et al. ANNALS OF THE RHEUMATIC DISEASES
- Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate
- (2011) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Model-based determination of abatacept exposure in support of the recommended dose for Japanese rheumatoid arthritis patients
- (2011) Mayumi Hasegawa et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Abatacept Plus Methotrexate Provides Incremental Clinical Benefits Versus Methotrexate Alone in Methotrexate-naive Patients with Early Rheumatoid Arthritis Who Achieve Radiographic Nonprogression
- (2011) A. F. WELLS et al. JOURNAL OF RHEUMATOLOGY
- Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
- (2011) VIVIAN P. BYKERK et al. JOURNAL OF RHEUMATOLOGY
- Improvements in Participation in Usual Daily Activities in Patients with Rheumatoid Arthritis Treated with Abatacept
- (2011) Tracy Li et al. VALUE IN HEALTH
- 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
- (2011) Timothy Beukelman et al. ARTHRITIS CARE & RESEARCH
- Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis
- (2011) Patricia Guyot et al. ARTHRITIS RESEARCH & THERAPY
- Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
- (2010) M. Schoels et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-Sleep questionnaire Sleep Disturbance Scale
- (2010) G. Wells et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
- (2010) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Abatacept Limits Breach of Self-Tolerance in a Murine Model of Arthritis via Effects on the Generation of T Follicular Helper Cells
- (2010) A. M. Platt et al. JOURNAL OF IMMUNOLOGY
- Decreased Circulating CD28-negative T Cells in Patients with Rheumatoid Arthritis Treated with Abatacept Are Correlated with Clinical Response
- (2010) M. SCARSI et al. JOURNAL OF RHEUMATOLOGY
- Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis
- (2010) Nicolino Ruperto et al. ARTHRITIS CARE & RESEARCH
- The efficacy and safety of abatacept in rheumatoid arthritis
- (2010) Rene Westhovens et al. Therapeutic Advances in Musculoskeletal Disease
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept, a Novel CD80/86-CD28 T Cell Co-stimulation Modulator, in the Treatment of Rheumatoid Arthritis
- (2009) Riku Korhonen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
- (2009) R. WESTHOVENS et al. JOURNAL OF RHEUMATOLOGY
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
- (2008) M H Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
- (2008) T A Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial
- (2008) M Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
- (2008) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Decreased external home help use with improved clinical status in rheumatoid arthritis: An exploratory analysis of the Abatacept in Inadequate Responders to Methotrexate (AIM) trial
- (2008) Tracy Li et al. CLINICAL THERAPEUTICS
- Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
- (2008) Nicolino Ruperto et al. LANCET
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
- (2007) H K Genant et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
- (2007) M Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept modulates human dendritic cell-stimulated T-cell proliferation and effector function independent of IDO induction
- (2007) Patricia M. Davis et al. CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started